Ex Parte Knapp - Page 7


                Appeal No. 2005-2690                                                                                                         
                Application No. 09/935,442                                                                                                   

                        warns of problems that may occur if fibrinogen and thrombin are separately                                           
                        introduced for in situ polymerization from such a spray method.  In this                                             
                        connection Delmotte states that “the lower the amount of residual                                                    
                        fibrinogen, the better the non-adhesive properties of the fibrin film, since                                         
                        fibrinogen in vivo may promote fibrin formation and thus adhesion                                                    
                        formation.”  (Col. 7, lines 1-4)(emphasis added).                                                                    
                        In view of the above, it would appear that Dinh suggests that it is critical that the                                
                final fibrin product coating the stent must be in a form so as to avoid clotting at the fibrin                               
                interface.  Also understood from Delmotte, is that the acceptability for medical use of the                                  
                final fibrin form upon polymerization in situ is dependent upon the amount and form of                                       
                the fibrinogen and thrombin used.  Added to these concerns, one of ordinary skill in the                                     
                art would have recognized at least some level of unpredictability associated with in situ                                    
                fibrin formation on a medical device, especially one implanted into the heart.                                               
                        Furthermore, Delmotte describes the application of fibrin glues and films to                                         
                prevent adhesions associated particularly with surgical procedures in the abdominal                                          
                cavity.  Column 1, lines 20-45.  Delmotte does not suggest that the medical devices                                          
                adapted to deliver fibrin to treat abdominal adhesions address the same or similar                                           
                problems associated with the prevention of vascular restenosis.                                                              
                        In supplement to the above, while the examiner argues “Delmotte suggests                                             
                different types of fibrin glues can be prepared by altering the amount of thrombin used                                      
                and allowing formation of fibrin at the site of administration by separately providing                                       
                fibrinogen and thrombin” (Answer, page 5), Delmotte does not provide for “separate                                           
                release” of the precursor and activator compounds from an adapted medical device for                                         
                local delivery, as claimed.  Instead, in the device of Delmotte, the precursor and activator                                 
                compounds begin in separate containers but are pressurized through a single spray unit,                                      


                                                                      7                                                                      



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007